Giles Coghlan LLB, Lth, MA
Financial Source
DexCom, Inc. is a global company headquartered in San Diego, California, that focuses on the development, manufacturing, and distribution of continuous glucose monitoring (CGM) systems for managing diabetes. These systems enable individuals with diabetes to monitor their blood glucose levels consistently throughout the day, aiding in effective diabetes management and treatment decision-making. With a strong international presence, DexCom serves customers worldwide, contributing significantly to advancements in diabetes care through its innovative CGM technology.
When there are recessionary risks healthcare companies can remain profitable as consumers understandably prioritize health care. DexCom has some impressive seasonal patterns outlined which have been found using the Seasonax screener feature.
Over the last 15 years, DexCom has gained 14 out of 15 times. With a very strong seasonal pattern and excellent annualized returns of over 115% and an average of 13.18%, the main question is if it is worth looking at DexCom as we head into the summer months.
Major Trade Risks: The major trade risk here is for stock-specific news to DexCom or if the seasonal pattern fails to hold up this year.
Our products and commentary provides general advice that do not take into account your personal objectives, financial situation or needs. The content of this website must not be construed as personal advice.
Recommended content
Editors’ Picks
EUR/USD clings to gains above 1.0750 after US data
EUR/USD manages to hold in positive territory above 1.0750 despite retreating from the fresh multi-week high it set above 1.0800 earlier in the day. The US Dollar struggles to find demand following the weaker-than-expected NFP data.
GBP/USD declines below 1.2550 following NFP-inspired upsurge
GBP/USD struggles to preserve its bullish momentum and trades below 1.2550 in the American session. Earlier in the day, the disappointing April jobs report from the US triggered a USD selloff and allowed the pair to reach multi-week highs above 1.2600.
Gold struggles to hold above $2,300 despite falling US yields
Gold stays on the back foot below $2,300 in the American session on Friday. The benchmark 10-year US Treasury bond yield stays in negative territory below 4.6% after weak US data but the improving risk mood doesn't allow XAU/USD to gain traction.
Bitcoin Weekly Forecast: Should you buy BTC here? Premium
Bitcoin (BTC) price shows signs of a potential reversal but lacks confirmation, which has divided the investor community into two – those who are buying the dips and those who are expecting a further correction.
Week ahead – BoE and RBA decisions headline a calm week
Bank of England meets on Thursday, unlikely to signal rate cuts. Reserve Bank of Australia could maintain a higher-for-longer stance. Elsewhere, Bank of Japan releases summary of opinions.